Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients

Last updated: April 24, 2014
Sponsor: Hospital General Universitario Elche
Overall Status: Completed

Phase

3

Condition

Diabetes Mellitus, Type 2

Diabetes (Pediatric)

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT02122874
2014-003
  • Ages > 18
  • All Genders

Study Summary

Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas and improves glycemic profile in diabetic patients

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • BMI>30 Kg/m2

  • Type 2 diabetes mellitus

  • Treatment with Metformin

Exclusion

Exclusion Criteria:

  • Under insulin treatment

  • Endocrinological disorders causing diabetes mellitus

Study Design

Total Participants: 60
Study Start date:
January 01, 2013
Estimated Completion Date:
April 30, 2014

Connect with a study center

  • General Hospital Elche

    Elche, Alicante 03203
    Spain

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.